- A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder. Keck, P.E., Calabrese, J.R., McQuade, R.D., Carson, W.H., Carlson, B.X., Rollin, L.M., Marcus, R.N., Sanchez, R. J. Clin. Psychiatry (2006)